ARID1A and liver cancer: In cirrhotic livers, somatic ARID1A mutations promote clonal expansion, potentially independently of carcinogenesis,[8] and may even confer protection against liver injury.[9] These same ARID1A‐inactivating mutations are also found in liver cancer, suggesting positive selection during disease progression.